Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Nov 17;174(1):227–235. doi: 10.1007/s10549-018-5048-8

Table 2.

Second breast cancer events according to initial treatment among 1,252 DCIS cases from the Vermont Breast Cancer Surveillance System.

All
(N=1,252)
Mastectomy
(N=201)
BCS alone
(N=327)
BCS + RT
(N=318)
BCS + RT and ET
(N=276)
BCS + ET
(N=130)
Median follow-up (years) 7.8 8.1 6.2 7.8 8.5 7.9
Any second event, N (rate per 100 person-years) 192 (2.0) 24 (1.5) 72 (3.6) 57 (2.3) 26 (1.1) 13 (1.3)
Ipsilateral event, N 114 6 55 29 14 10
Contralateral event, N 69 17 15 25 10 2
Bilateral event, N 7 0 2 2 2 1
Distant events, N 2 1 0 1 0 0
Invasive event, N 126 16 45 40 15 10
DCIS event, N 66 8 27 17 11 3
Ipsilateral invasive, N 74 6 33 19 9 7
Ipsilateral DCIS, N 40 0 22 10 5 3
Contralateral Invasive, N 45 9 11 18 5 2
Contralateral DCIS, N 24 8 4 7 5 0
Bilateral invasive, Na 5 0 1 2 1 1
Bilateral DCIS, Na 2 0 1 0 1 0

Abbreviations: BCS, breast conserving surgery. DCIS, ductal carcinoma in situ; ET, endocrine therapy; RT, radiation therapy.

a

A bilateral diagnosis was counted as invasive if either or both breasts had an invasive second event and as DCIS if both breasts had DCIS.